Icon

OFEV (nda205832)- (EQ 100MG BASE,EQ 150MG BASE)

NINTEDANIB ESYLATE BOEHRINGER INGELHEIM
EQ 100MG BASE,EQ 150MG BASE
Yes No
2029-Dec-07 2019-Oct-15
2021-Oct-15 None
None No
OFEV is a kinase inhibitor indicated in adults for: • Treatment of idiopathic pulmonary fibrosis (IPF). • Treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype • Slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
0 4 0
Total Other Developers 14
Drugs with Suitability No
EQ 100MG BASE ** ** - - -
EQ 150MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.